Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 425 of 2406 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/08/23
End: 10/12/26
Due: 10/12/27
Phase: N/A
Priority: Normal
Start: 05/01/23
End: 12/31/26
Due: 12/31/27
The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 05/31/21
End: 10/31/23
Due: 10/31/24
Phase: N/A
Priority: Normal
Start: 12/12/18
End: 04/16/21
Due: 04/16/22
Phase: N/A
Priority: Normal
Start: 01/01/25
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 03/15/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 08/01/17
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 08/31/04
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 07/13/23
End: 09/15/23
Due: 09/15/24
Phase: N/A
Priority: Normal
Start: 12/22/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 10/17/18
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 06/30/15
Due: 06/30/16
Phase: N/A
Priority: Normal
Start: 01/22/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 06/30/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/01/21
End: 03/16/22
Due: 03/16/23